-
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Bolsewig, K., Willemse, E. A. J., Sánchez-Juan, P., Rábano, A., Martínez, M., Doecke, J. D., Bellomo, G., Vermunt, L., Alcolea, D., Halbgebauer, S., in 't Veld, S., Mattsson-Carlgren, N., Veverova, K., Fowler, C. J., Boonkamp, L., Koel-Simmelink, M., Hussainali, Z., Ruiters, D. N., Gaetani, L. & Toja, A. & 12 others, , Dec 2025, In: Nature communications. 16, 1, p. 1139 1 p., 1139.Research output: Contribution to journal › Article* › Academic › peer-review
-
Caregivers’ attitudes toward blood-based biomarker testing for Alzheimer's disease
Bolsewig, K., Blok, H., Willemse, E. A. J., Zwaaftink, R. B. M. G., Kooistra, M., Smets, E. M. A., Teunissen, C. E. & Visser, L. N. C., 1 Jan 2024, In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 16, 1, e12549.Research output: Contribution to journal › Article* › Academic › peer-review
-
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies
Bolsewig, K., Van Unnik, A. A. J. M., Blujdea, E. R., Gonzalez, M. C., Ashton, N. J., Aarsland, D., Zetterberg, H., Padovani, A., Bonanni, L., Mollenhauer, B., Schade, S., Vandenberghe, R., Poesen, K., Kramberger, M. G., Paquet, C., Bousiges, O., Cretin, B., Willemse, E. A. J., Teunissen, C. E. & Lemstra, A. W., 2024, In: Neurology. 102, 12Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
